First signal-finding study of soluble HLA-G and -E (sHLA-G/E) as potential prognostic markers of clinical outcome in advanced, refractory squamous-cell NSCLC (SCC) treated with nivolumab (NIVO) : checkMate 063

Authors :: Eberhardt, Wilfried
Rebmann, Vera
Rizvi, N.
Antonia, S. J.
Planchard, D.
Cappuzzo, F.
Mazieres, J.
Zalcman, G.
Lena, H.
Wolf, J.
Horn, L.
Stinchcombe, T.
Dy, G.
Blackwood-Chirchir, A.
Jin, C.
Geese, W. J.
Ramalingam, S. S.
Publication Year :: 2017

Tools